Table 2 Results of virological and genotypic resistance testing by cohort
| Â | Cohort M12 | Cohort M24 |
|---|---|---|
HIV RNA ≥ 1,000 copies/ml (%) | 25 | 50 |
Available genotypic resistance (%) | 20 (80.0) | 42 (84.0) |
Wild-type virus (%) | 6 (30.0) | 10 (23.8) |
Resistance to ≥ 1 ARV drug (%) | 14 (70.0) | 32 (76.2) |
Resistance to EFV and NVP (%) | 3 (15.0) | 1 (2.4) |
Resistance to 3TC, EFV, and NVP (%) | 9 (45.0) | 22 (52.4) |
Extensive resistance* (%) | 2 (10.0) | 9 (21.4) |